People · Operator
Named in public records as an officer, director or promoter · active 2012–2022 · Pharmaceuticals, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Jaguar Health, Inc. | — | Pharmaceuticals | Series C | $151.1M | $58.9M | 2014 |
| Torigen Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $10.9M | $62.1M | 2020 |
| Bactana Corp. | — | Biotechnology | Seed | $1.7M | $5.7M | 2018 |
| IB Direct, LLC | — | Other Technology | Seed | $1.5M | $51.1M | 2012 |
John Kallassy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Kallassy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| KEVIN CROWLEY | 1 | 9 |
| Peter Longo | 1 | 8 |
| David Wurzer | 1 | 7 |
| Steven King | 1 | 6 |
| Jonathan Siegel | 1 | 5 |
| James J. Bochnowski | 1 | 5 |
| Anula Jayasuriya | 1 | 5 |
| Pravin Chaturvedi | 1 | 4 |
| James Bochnowski | 1 | 4 |
| Serge Martinod | 1 | 3 |
| Lisa Conte | 1 | 3 |
| Ari Azhir | 1 | 3 |
| Chen Wang | 1 | 3 |
| Jeffery Johnson | 1 | 2 |
| Charles Thompson | 1 | 2 |
| Karen S. Wright | 1 | 2 |
| Elizabeth Galbut | 1 | 2 |
| Carol Lizak | 1 | 2 |
| John Micek III | 1 | 2 |
| Zhi Yang | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.